Does MIPOMERSEN Cause Injection site warmth? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Injection site warmth have been filed in association with MIPOMERSEN. This represents 6.0% of all adverse event reports for MIPOMERSEN.
12
Reports of Injection site warmth with MIPOMERSEN
6.0%
of all MIPOMERSEN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site warmth From MIPOMERSEN?
Of the 12 reports, 1 (8.3%) required hospitalization.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIPOMERSEN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MIPOMERSEN Cause?
Injection site pain (67)
Hepatic enzyme increased (48)
Injection site erythema (48)
Influenza like illness (36)
Injection site bruising (31)
Fatigue (26)
Nausea (24)
Injection site discolouration (23)
Injection site swelling (23)
Injection site rash (18)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which MIPOMERSEN Alternatives Have Lower Injection site warmth Risk?
MIPOMERSEN vs MIRABEGRON
MIPOMERSEN vs MIRALAX
MIPOMERSEN vs MIRCERA
MIPOMERSEN vs MIRENA
MIPOMERSEN vs MIRIKIZUMAB-MRKZ